Noam Vanderwalde is an Oncology physician affiliated with West Cancer Center. OpenAlex indexes 100 publications with 1,431 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7945 Wolf River Blvd
Germantown, TN 381381733
Telephone
901-683-0055Registry record last updated 5 Apr 2016.
Clinical trials
- The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older
Sponsor: The West Clinic, Memphis
- Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Elekta, Inc.Program year20253 payments
- Novocure Inc.Program year20252 payments
- Caris MPI, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Sulfonamide Antibacterial100%Silver Sulfadiazine100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicting future cancer incidence by age, race, ethnicity, and sex
Journal of Geriatric Oncology
2022 - Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology
Journal of Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ari Vanderwalde, MD
West Cancer Center
Daniel Vaena, MD
West Cancer Center
Gregory Vidal, MD
West Cancer Center
David Portnoy, MD
West Cancer Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”